In Brief: FDA's Antiviral Drugs Advisory Committee
Executive Summary
FDA's Antiviral Drugs Advisory Committee: Panel will meet in closed session on Feb. 21 to review confidential information relevant to pending INDs and drug development plans. The meeting will be held at the Hilton in Gaithersburg, Md. An open public hearing will be held at 8:30 a.m., prior to closed discussions...